
Lean Rx Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.8/10
Best for: Patients wanting compounded GLP-1 in injectable, sublingual, or tablet form
Lean Rx is a solid telehealth option with balanced features and pricing.
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Not disclosed
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Lean Rx is a Sacramento-based telehealth technology platform offering compounded GLP-1 weight loss medications. Patients complete an online medical history and a telehealth call with an independent licensed provider, who prescribes when appropriate, then receive medication shipped home. Lean Rx offers compounded semaglutide from $266 per month and tirzepatide from $399 per month, in injectable, sublingual, and tablet forms. It advertises upfront pricing with no hidden fees, and notes it is a technology platform, not a healthcare provider. No state list is published.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Lean Rx
Sunlight
Best for: compounded GLP-1 with unlimited telehealth visits and free shipping
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Lean Rx at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Compounded semaglutide, Compounded tirzepatide
- Starting price
- $266/mo
- What's included
- Medication
- FDA status
- No FDA warning letter on record
How we scored Lean Rx
Each dimension is scored algorithmically from Lean Rx’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
5.5/10At $266/mo, Lean Rx runs about 57% above the $170 median for GLP-1 providers.
Effectiveness25%
8.2/10Lean Rx offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.2/10Online intake and platform experience; 8 platform features disclosed.
Trust & Safety15%
7.3/10Core details confirmed by our editors; no FDA warning letters on file (last checked 2026-06-06).
Accessibility10%
6.1/10Lean Rx's exact state footprint isn't published — confirm coverage in your state before signing up.
Support10%
5.9/10Lean Rx provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Lean Rx review
Last checked July 2026- Confirmed current pricing across 2 dose/plan tiers
- Confirmed what the monthly price does and doesn't include
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What to expect when you sign up with Lean Rx
We walked Lean Rx’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Schedule a brief online consultation.
- 2Complete a medical history.
- 3Have a telehealth call with a licensed provider who prescribes a weight-loss plan if appropriate.
- 4Receive medication delivered quickly and discreetly.
- Upfront pricing shown: tirzepatide starting at $399 and semaglutide at $266, with an 'upfront pricing, no hidden fees' claim.
- Prescribes tirzepatide and semaglutide via telehealth.
- A telehealth call with a licensed provider is required before prescribing.
- Medication ships 'quickly and discreetly' but no specific timeframe is stated.
- Policies are linked but not detailed on the page; no phone or email is displayed on the homepage.
GLP-1 medications Lean Rx offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Pricing
Prices re-verified
Ready to get started?
Plans and promotions change often — check Lean Rx's current pricing and active discounts before you decide.
What we like
- Both semaglutide and tirzepatide offered
- Three formulations: injectable, sublingual, and tablet
- Upfront pricing with no hidden fees advertised
- Semaglutide starts at a low $266/month
- Telehealth call with a licensed provider before prescribing
Watch-outs
- Compounded-only; no FDA-approved branded options
- No published state availability list
- Platform is technology only, not a healthcare provider itself
- Provider credentials not detailed on site
Lean Rx: a Sacramento tech platform that hands prescribing to outside clinicians
Lean Rx is best understood for what it openly says it is: a telehealth technology platform, not a medical practice. The company, Lean Rx, Inc., is based in Sacramento, California, and its job is to run the software, the intake, and the logistics. The actual prescribing is done by independent licensed clinicians who review your medical history and meet you on a telehealth call. If a prescription is appropriate, your compounded medication ships to your door. That structure is common in this space, but Lean Rx is unusually upfront about it, and that honesty is a fair starting point for deciding whether it fits you.
The real reason to look at Lean Rx is price plus format flexibility. Compounded semaglutide starts at $266 a month and compounded tirzepatide starts higher, and you can get either as an injection, a sublingual, or a tablet. That combination of a low entry price and three delivery forms is the specific thing that sets it apart.
How the pricing actually works
Lean Rx advertises 'upfront pricing, no hidden fees,' and the figures on its site match what we verified: semaglutide from $266 per month, tirzepatide from a higher starting point. The word that matters most there is 'starting.' These are from-prices for the lowest dose. The site does not publish a full per-dose price list, so it is not clear whether your cost holds steady as your dose climbs over the months, which is exactly when many compounded programs get more expensive. Treat $266 as the floor, not the lifetime number, and confirm the higher-dose pricing on a call before you commit.
For context, the entry price sits well above the category median of $170, but compounded GLP-1 programs vary widely and the median lumps in teaser and membership rates. There is no first-month promo rate baked into the listing. The site does mention very cheap discovery calls and a free consultation, which is a low-friction way to get pricing confirmed for your situation before any medication charge.
What the monthly price covers
The medication itself is included in the quoted price. What is less clear is whether consultations, shipping, lab work, or coaching are bundled in or billed separately — the homepage does not spell those out either way. That is a normal question to ask any compounding telehealth service, and with Lean Rx you will want to ask it directly rather than assume.
The medications and the three formats
You can get compounded semaglutide (the molecule in Ozempic and Wegovy) or compounded tirzepatide (the molecule in Mounjaro and Zepbound). Both are the major GLP-1 options for weight loss, and offering both is a genuine plus — many cheaper programs carry only semaglutide.
The standout is form. Most telehealth GLP-1 services ship a weekly self-injection and nothing else. Lean Rx offers injectable, sublingual (dissolved under the tongue), and tablet versions. If needles are the single thing keeping you from trying a GLP-1, that flexibility is meaningful. Be realistic, though: injectable GLP-1s are the form with the deepest clinical track record, and oral or sublingual compounded versions are less studied. Choose a non-injection format for needle avoidance, not because you expect identical results.
- Compounded semaglutide — from $266/month, the lower-cost entry point
- Compounded tirzepatide — higher starting price, the dual-action option
- Three forms — injectable, sublingual, or tablet, your choice
What sets Lean Rx apart
Two things, really. First, the format menu — few competitors give you a needle-free path to both semaglutide and tirzepatide. Second, the plainspoken framing: Lean Rx tells you outright that it is a technology platform and that licensed clinicians, not the company, do the prescribing. Some shoppers will read that as refreshing transparency; others will want a service that presents itself as a unified medical provider. Either way, you know what you are signing up for.
Who should choose it — and who should skip it
Lean Rx makes sense if you want a low semaglutide entry price, you specifically want a sublingual or tablet option, or you want access to both major GLP-1 molecules from one service. The pre-prescription telehealth call with a licensed provider is a reasonable safety step rather than a pure questionnaire.
Skip it if you need an FDA-approved brand-name drug — Lean Rx is compounded-only, with no branded Ozempic, Wegovy, Mounjaro, or Zepbound on the menu. Skip it too if you want to confirm up front that your state is served: Lean Rx publishes no state availability list, so you will have to check coverage during intake. And if detailed clinician credentials matter to you before you hand over a medical history, note that the site does not name the prescribing providers or their qualifications in detail.
Trust, safety, and our confidence level
There are no FDA warning letters on file for Lean Rx, which is a clean baseline. The telehealth-call-before-prescribing model is the kind of oversight we like to see. We rate our overall confidence here as medium rather than high — not because of any red flag, but because of what is missing from the public record: no published state list, no named clinicians or stated credentials, and no detail on the compounding pharmacy or its accreditation. Compounded medications are not FDA-approved for safety and efficacy the way branded GLP-1s are, so the pharmacy behind them genuinely matters, and here it is not disclosed. You can see how we weigh these factors in our scoring methodology.
Bottom line
Lean Rx is a credible, honestly framed compounding platform with a real edge: a low semaglutide starting price and a rare three-format menu covering both semaglutide and tirzepatide, including needle-free options. It is held back by thin public disclosure — no state list, no named prescribers, no pharmacy accreditation on record — which is why we land at medium confidence. If the flexible formats or the entry price are what you are after, it is worth a discovery call. Just press for two specifics before you pay: the pricing at the higher doses you will eventually reach, and which pharmacy compounds your medication.
Worth pricing against Direct Meds ($249/month) and bmiMD ($99/month) before you commit — both sit close to Lean Rx on cost and formulation.
The Bottom Line
Lean Rx is a solid telehealth option with balanced features and pricing.
Ready to start with Lean Rx?
Starting at $266/month. See current pricing and start your free consultation.
Lean Rx might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Sesame Care (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Found.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Lean Rx review:
Sources & methodology — as of July 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Lean Rx's current pricing
Plans start at $266/month. Start your free consultation to check eligibility and today's price.